Biochemical assessment of myocardial fibrosis in hypertensive heart disease

Hypertension

Volumn 38, Issue 5, 2001, Pages 1222-1226

  López, Begoña ^a   González, Arantxa ^a   Varo, Nerea ^a   Laviades, Concepción ^a   Querejeta, Ramón ^a   Díez, Javier ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Collagen; Hypertension, essential; Myocardium; Remodeling; Renin angiotensin system

Indexed keywords

ANTIHYPERTENSIVE AGENT; COLLAGEN TYPE 1; COLLAGEN TYPE 2; LOSARTAN; PROCOLLAGEN; QUINAPRIL;

ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; HEART FUNCTION; HEART MUSCLE FIBROSIS; HEART PROTECTION; HYPERTENSION; MALE; NON INVASIVE MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN METABOLISM; RADIOIMMUNOASSAY; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEROLOGY;

EID: 0035726137     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/hy1101.098549     Document Type: Conference Paper

References (30)

1. Fibrosis and hypertensive heart disease
2. Collagen matrix synthesis and degradation in the development and regression of left ventricular hyperthrophy
3. Myocardial fibrosis in hypertensive heart disease: An overview of potential regulatory mechanisms
4. Angiotensin II and connective tissue: Homeostasis and reciprocal regulation
5. Regulation of cardiac collagen: Angiotensin and cross-talk with local growth factors
6. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle
7. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease
8. Repair of coronary arterioles after treatment with perindropil in hypertensive heart disease
9. Ventricular arrhythmias in hypertensive left ventricular hypertrophy. Relationship to coronary artery disease, left ventricular dysfunction, and myocardial fibrosis
10. Echocardiographic patterns of myocardial fibrosis in hypertensive patients: Endomyocardial biopsy versus ultrasonic tissue characterization
11. Monitoring fibrillar collagen turnover in hypertensive heart disease
12. Quinapril decreases myocardial accumulation of extracellular matrix components in spontaneously hypertensive rats
13. Alterations in the extracellular matrix of the myocardium in essential hypertension
14. Fibrillar collagens: Their biosynthesis, molecular structure, and mode of assembly
15. Circulating C-terminal propeptide of type I procollagen is cleared mainly via a mannose receptor in the liver endothelial cells
16. Noninvasive methods for detection of organ fibrosis
17. Collagen degradation in the heart
18. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: A new serum marker of bone collagen degradation
19. Serum markers of collagen type I metabolism in spontaneously hypertensive rats: Relation to myocardial fibrosis
20. Losartan inhibits the post-transcriptional synthesis of collagen type I and reverses left ventricular fibrosis in spontaneously hypertensive rats
21. 1 blockade stimulates extracellular collagen type I degradation and reverses myocardial fibrosis in spontaneously hypertensive rats
22. Is the extracellular degradation of collagen type I fibers depressed in spontaneously hypertensive rats with myocardial fibrosis?
23. Increased serum concentrations of procollagen peptides in essential hypertension: Relation to cardiac alterations
24. Abnormalities of the extracellular degradation of collagen type I in essential hypertension
25. Transforming growth factor β in hypertensives with cardio-renal damage
26. Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease
27. Usefulness of serum carboxy-terminal propeptide of procollagen type I to assess the cardioreparative ability of antihypertensive treatment in hypertensive patients
28. Dynamic state of collagen: Pathways and collagen degradation in vivo and their possible role in regulation of collagen mass
29. Pharmacological modulation of cardiac fibroblast function
30. Targeting pathological remodeling: Concepts of cardioprotection and reparation